Astera Labs (NASDAQ:ALAB) Stock Price Target Cut by TD Cowen

Astera Labs (NASDAQ:ALAB) had its price target lowered by analysts at TD Cowen from $375.00 to $300.00 in a research report issued on Monday, Benzinga reports. The firm presently has a “hold” rating on the stock. TD Cowen’s target price would indicate a potential upside of 4.68% from the company’s current price.

A number of other research analysts also recently issued reports on the company. Roth Capital restated a “buy” rating and set a $450.00 price target on shares of Astera Labs in a report on Wednesday, August 5th. Citigroup cut Astera Labs from a “buy” rating to a “hold” rating in a research note on Friday, October 9th. Bank of America boosted their target price on Astera Labs from $240.00 to $450.00 and gave the company a “neutral” rating in a research note on Tuesday, June 23rd. Morgan Stanley upped their target price on Astera Labs to $335.00 and gave the company an “overweight” rating in a report on Monday, August 3rd. Finally, Northland Securities lowered Astera Labs from an “outperform” rating to a “market perform” rating in a research note on Friday, October 9th. Eleven equities research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. According to MarketBeat.com, Astera Labs currently has an average rating of “Moderate Buy” and an average price target of $344.17.

Astera Labs Trading Up 0.3%

Shares of NASDAQ:ALAB opened at $286.58 on Monday. The company has a market cap of $49.72 billion, a price-to-earnings ratio of 141.87 and a beta of 3.68. The company has a 50-day moving average price of $314.24 and a 200-day moving average price of $299.64. Astera Labs has a 12 month low of $97.89 and a 12 month high of $499.48.

Astera Labs (NASDAQ:ALAB) last posted its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. The company had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. Astera Labs’s revenue for the quarter was up 104.5% on a year-over-year basis. During the same period in the prior year, the business posted $0.44 earnings per share. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, research analysts forecast that Astera Labs will post 2.70 EPS for the current fiscal year.

Insider Activity

In related news, Director Manuel Alba sold 183,000 shares of the stock in a transaction dated Tuesday, September 1st. The shares were sold at an average price of $280.13, for a total value of $51,263,790.00. Following the completion of the transaction, the director directly owned 253,863 shares of the company’s stock, valued at $71,114,642.19. This represents a 41.89% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 90,630 shares of the firm’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the sale, the chief executive officer owned 1,266,665 shares of the company’s stock, valued at $431,109,432.75. This trade represents a 6.68% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last three months, insiders have sold 408,558 shares of company stock worth $127,306,034. 10.40% of the stock is owned by company insiders.

Institutional Trading of Astera Labs

Several large investors have recently bought and sold shares of ALAB. BlackRock Inc. purchased a new position in Astera Labs in the 2nd quarter worth approximately $6,609,581,000. ABS Investment Management LLC bought a new position in Astera Labs in the 2nd quarter valued at approximately $1,980,382,000. Van ECK Associates Corp lifted its position in Astera Labs by 20.0% in the 2nd quarter. Van ECK Associates Corp now owns 2,237,961 shares of the company’s stock valued at $1,080,980,000 after acquiring an additional 373,545 shares in the last quarter. Bank of America Corp DE bought a new position in Astera Labs in the 2nd quarter valued at approximately $1,061,791,000. Finally, Atreides Management LP purchased a new stake in Astera Labs during the 2nd quarter valued at $587,736,000. 60.47% of the stock is owned by institutional investors.

Astera Labs Company Profile

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.